The research Dr. Yvonne Maldonado has conducted has been focused on epidemiologic aspects of viral vaccine development and prevention of perinatal HIV transmission. A major project has been to identify the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) among children living in developing areas of the world, where OPV immunogenicity is poor. Dr. Maldonando's group has identified several factors which affect the poor immunogenicity of OPV and will conduct clinical studies to attempt to improve immunogenicity.

Dr. Domingue has two areas of active research: The first focuses on statewide standardized test scores and their uses, particularly how test scores are used in statistical models that evaluate the effectiveness of teachers and schools; the second area of research focuses on the integration of genetic data into social science research.

The Khatri Lab focuses on novel translational bioinformatics approaches to translation medicine in the broad domains of autoimmunity, infection, and inflammation.

Dr. Felt's research interests include infectious diseases, particularly zoonoses, and exploring techniques which promote the health and welfare of laboratory animals.

The overall theme of Dr. Knowles's work is to understand the genetic basis of complex cardiovascular diseases such as coronary disease and insulin resistance.

Dr. Mackall is an expert in the field of T cell homeostasis, and her group was one of the first to demonstrate the success of a cancer therapy for pediatric acute lymphoblastic leukemia that works by modifying the patient’s own immune cells.

The Bertozzi Group studies cell surface interactions that contribute to human health and disease with specific projects in the areas of cancer, inflammation and bacterial infection.

The Woo lab uses cardiac surgery and coronary ligation as a model to study ischemic cardiomyopathy and stem cell biology, as well as to test novel molecular and cellular therapeutics.

The LaBeaud lab's main research questions focus on the risk factors for arboviral infections, the development of diagnostic tests that can be administered in the field to quickly determine what kind of arboviral infection a person has, and the genetic and immunologic investigation of why different people respond differently to the same infection.

Dr. Wendy Fantl’s lab studies two key questions with unmet clinical need related to drug resistance and immunotherapy focusing on ovarian and kidney cancers. The lab applies multi-parametric single-cell proteomic technologies (mass cytometry aka Cytometry by Time-Of-Flight (CyTOF) and multiplex imaging (CO-Detection by indEXing (CODEX)) combined with specialized computational approaches to address these questions.